News

October 31, 2019October 31, 2019

Alaxia Joins iABC Consortium to Accelerate Development of ALX-009, Its Lead Antimicrobial Agent

News

Alaxia has joined the inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis (iABC) consortium as a partner in a collaborative project that seeks to accelerate the development of two inhaled antimicrobial ... Read more

October 24, 2019October 24, 2019

Inhaled Ciprofloxacin May Help Prevent Bronchiectasis Exacerbation, but More Studies are Needed, Review Suggests

News

Treatment with inhaled ciprofloxacin medications — such as Aradigm’s Apulmiq or Bayer’s Ciprofloxacin DPI investigational therapies — holds potential to prevent acute worsening of respiratory problems in patients with bronchiectasis, ... Read more

October 17, 2019October 17, 2019

Bronchiectasis Affects More People in UK than Previously Thought, with Number of Cases Rising, Survey Says

News

The incidence of non-cystic fibrosis bronchiectasis is increasing in the United Kingdom (U.K.), with the number of cases much higher than previously thought, according to a survey commissioned by the British ... Read more

October 10, 2019October 10, 2019

Pregnancy-related Protein Linked to Chest Infections and Bronchiectasis Severity, Study Suggests

News

A protein associated with pregnancy is linked to disease severity and frequent exacerbations in people with bronchiectasis and chronic chest infections (that are mostly caused by Pseudomonas aeruginosa), a study ... Read more

October 3, 2019October 3, 2019

Amoxicillin-Clavulanate Recommended to Treat Non-severe Flare-ups of Bronchiectasis in Children, Trial Shows

News

The combination of amoxicillin with clavulanate should remain the oral antibiotic of choice to treat non-severe flare-ups of bronchiectasis in children, results of a Phase 4 trial indicate. The trial’s ... Read more

September 27, 2019September 27, 2019

NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC

News

Next month’s annual conference of the National Organization for Rare Disorders (NORD) in Washington, D.C., couldn’t come at a better time, says Marshall Summar, MD, chairman of NORD’s board of ... Read more

September 26, 2019September 26, 2019

Study Examines Risk Factors for Bacterial Colonization in Bronchiectasis

News

Among people with bronchiectasis, those more than 55 years old or who have bronchiectasis as a result of infection, are at an increased risk of being colonized with the bacteria Pseudomonas ... Read more

September 5, 2019September 5, 2019

Long-term Macrolide Treatment Linked to Significant Reduction in Bronchiectasis Exacerbations, Study Shows

News

Long-term treatment with macrolides — a class of antibiotics — is associated with a significant reduction in the frequency of exacerbations in people with bronchiectasis, a study shows. The study, ... Read more

September 2, 2019August 30, 2019

‘Disorder’ Film Festival Offers Look at Siblings Touched by Rare Diseases

News

Rare diseases deeply affect not only the children who experience them, but also their healthy brothers and sisters, as their parents can attest. Two entries in November’s “Disorder: The ... Read more

August 29, 2019August 29, 2019

New Distribution Partnerships for SmartVest System Announced

News

Electromed has entered into new agreements with two home medical equipment distributors to enhance the distribution of and facilitate access to its SmartVest Airway Clearance System for people with respiratory ... Read more